The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study
Official Title: Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study
Study ID: NCT03121729
Brief Summary: This study is aimed to evaluate the safety of applying enhanced recovery after surgery for gastric cancer.
Detailed Description: In China, gastric cancer results in the second highest morbidity and mortality rates among all malignancies. It is very important for treatment of gastric cancer to enhance the quality of treatment, increase patients' survival rate and improve the life quality. Now, "Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology" and "Japanese gastric cancer treatment guidelines 2014 (ver. 4)" recommended surgical resection for gastric cancer. As a result, increasing the quality of surgery and improving the perioperative measures have a great influence on patients received a gastrectomy. Before, patients discharged on 7-10 days after gastrectomy and recovered 4-8 weeks after surgery. So, it is significant for patients to recover from surgical trauma in order to receive other anti-cancer therapies after gastrectomy. Investigators spent over ten years studying enhanced recovery after surgery programs for gastric cancer and have got some successful experience. Investigators found enhanced recovery after surgery can accelerate patients' recovery without increasing complications. This study is the first multi-center study of enhanced recovery after surgery for gastric cancer all over the world. During this period, the study is aimed to evaluate the safety of applying enhanced recovery after surgery for gastric cancer.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu, China
The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu, China
The Second People's Hospital of Lianyungang City, Lianyungang, Jiangsu, China
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
Nanjing First Hospital, Nanjing, Jiangsu, China
Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China
Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Suqian People's Hospital, Nanjing Drum Tower Hospital, Suqian, Jiangsu, China
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
The First People's Hospital of Taicang, Suzhou, Jiangsu, China
Zhangjiagang First People's Hospital, Suzhou, Jiangsu, China
the Taizhou People's Hospital, Taizhou, Jiangsu, China
The 101 Hospital of the Chinese People's Liberation Army, Wuxi, Jiangsu, China
Affiliated Hospital of Jiangnan University, The Forth People's Hospital of Wuxi City, Wuxi, Jiangsu, China
Xuzhou Central Hospital, Xuzhou, Jiangsu, China
Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China
Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China
Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China
Name: Zhi-Wei JIANG, Ph.D.
Affiliation: Jinling Hospital, Medical School of Nanjing University
Role: PRINCIPAL_INVESTIGATOR
Name: Jian ZHAO, Ph.D.
Affiliation: Jinling Hospital, Medical School of Nanjing University
Role: STUDY_DIRECTOR
Name: Gang WANG, Ph.D.
Affiliation: Jinling Hospital, Medical School of Nanjing University
Role: STUDY_DIRECTOR
Name: Jiang LIU, M.D.
Affiliation: Jinling Hospital, Medical School of Nanjing University
Role: STUDY_DIRECTOR